Latest Health News
US HIV Funding Disruptions Hit Clinics Hard at CROI 2026
At the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, experts discussed impacts of US PEPFAR funding cuts under the Trump administration. Clinics in 32 countries reported 28% medication challenges, 34% lab disruptions, and 47% operational issues like patient tracing. South Africa faced additional cuts due to geopolitical tensions, eroding trust in health systems.
Branaplam Lowers Huntingtin in HD Trial but Halted by Safety Issues
Published results from the VIBRANT-HD trial show oral drug branaplam reduced expanded HTT levels by ~25% in spinal fluid of Huntington's disease patients. However, 75% of participants experienced reversible nerve damage, leading to early trial termination.
Findings validate NfL as a safety biomarker for next-generation HTT-lowering drugs.
AMA Pushes Medicare Reforms and AI Adoption at Advocacy Conference
During the AMA National Advocacy Conference, physicians advocated for Medicare payment reform, prior authorization fixes, and Medicaid access protection on Capitol Hill. AMA awarded Outstanding Government Service and commented on HHS RFI for accelerating AI in clinical care, stressing transparency and risk-based regulation.
Concerns include physician liability and reimbursement for AI technologies.
US Restores $15B in Global Health Funding After Proposed Cuts
A January budget deal with Congress restores $15 billion in cuts to US global health, multilateral, and humanitarian programs for FY2026. This mitigates impacts compared to prior proposals, though total US aid cuts from 2024-2026 stand at -23%.
UN faces funding crisis with $1.56B in unpaid contributions, risking collapse by July.
Breakthroughs in Diabetes Care: Artificial Pancreas and Stem Cells Advance
Hybrid artificial pancreas systems with CGMs and insulin pumps automate glucose management, shrinking devices to coin-sized patches. Innovations include immune-evasive stem-cell beta cells in protective capsules and smart insulins that respond to glucose levels.
These could make many current treatments obsolete.
WHO Tests '7-1-7 Strategy Game' to Boost Outbreak Response Speed
WHO is piloting an interactive strategy game to enhance outbreak detection within 7 days, notification in 1 day, and response in 7 days. The game trains public health teams on the 7-1-7 targets for faster epidemic control.
Testing aims to improve global outbreak preparedness.
J&J's Pasritamig Plus Docetaxel Shows Deep Responses in Prostate Cancer
Phase 1b results from Johnson & Johnson reveal pasritamig, a T-cell engager targeting KLK2, combined with docetaxel yields deep PSA responses and favorable safety in advanced prostate cancer. The prostate-specific approach allows office administration.
Plans advance to Phase 3 trials.
US Signs 19 Global Health MOUs Including DRC Under America First Strategy
As of February 26, 2026, the US State Department signed 19 bilateral global health Memoranda of Understanding, including with DRC, Botswana, and others. This implements the America First Global Health Strategy.
Agreements aim to reshape international health partnerships.
Stanford Unveils Universal Vaccine Against Multiple Infectious Diseases
Stanford Medicine scientists developed a 'universal' vaccine potentially protecting against COVID and other diseases. Separately, a reengineered HPV vaccine enhances T-cell targeting of cancer, and a CRISPR tool combats antibiotic resistance.
These address looming superbug crises projected to cause 10M deaths yearly by 2050.
Canada Invests $41M in Cancer Prevention and Early Detection Research
Government of Canada and partners allocate over $41M to advance cancer prevention, risk reduction, and early detection, potentially preventing 4 in 10 cases. Funding supports research through Canadian Institutes of Health Research.
Announcement made February 26, 2026, in Toronto.
New CAG Sequence Insights Shift HD Symptom Onset by Up to 13 Years
Research identifies DNA sequence patterns in CAG repeats that can advance Huntington's disease onset by up to 13 years and double progression speed. Standard tests miss these variations, impacting genetic counseling and trials.
A new variant was discovered.
WHO Hosts Frontiers in MCM R&D on Immunology and Genomics Breakthroughs
WHO event on February 26-27, 2026, explores breakthroughs in immunology, genomics, and synthetic biology for medical countermeasures R&D. Focuses on live advancements in outbreak response tools.
Aims to converge innovations for global health threats.